DIOVAN HCT Adverse Event: Gastrointestinal stromal tumour
DIOVAN HCT Adverse Event: Gastrointestinal stromal tumour is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: DIOVAN HCT; Product category: Drug; Primary reaction: Gastrointestinal stromal tumour.
| Primary drug | DIOVAN HCT |
|---|---|
| Product category | Drug |
| Primary reaction | Gastrointestinal stromal tumour |
| All reactions | Gastrointestinal stromal tumour; Malaise; Hepatic neoplasm; Wrong technique in drug usage process |
| Seriousness | Serious |
| Patient outcome | Recovering/Resolving |
| Patient sex | Male |
| All drugs reported | DIOVAN HCT |
| Reporter country | BR |
| Reporter type | 5 |
| Report date | 20140312 |
| Report ID | 10003949 |
$299/mo
Try FDATracker →